Stereotactic radiotherapy for pancreatic cancer?
Open Access
Abstract
Although the authors of 1 report in this issue have proposed the use of stereotactic body radiotherapy (SBRT) for patients with pancreatic cancer, other authors have associated SBRT with poor outcomes, unacceptable toxicity, and questionable palliative effect. The results of this study do not support the use of SBRT for pancreatic cancer outside of a clinical trial setting.Keywords
This publication has 17 references indexed in Scilit:
- Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreasCancer, 2009
- Gemcitabine Chemotherapy and Single-Fraction Stereotactic Body Radiotherapy for Locally Advanced Pancreatic CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- A Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: RTOG PA0411International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinomaAnnals of Oncology, 2007
- A Phase II Study of Fixed-Dose Rate Gemcitabine Plus Low-Dose Cisplatin Followed by Consolidative Chemoradiation for Locally Advanced Pancreatic CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic CancerJournal of Clinical Oncology, 2006
- Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinomaRadiotherapy and Oncology, 2005
- Long-term Results of Intraoperative Electron Beam Irradiation (IOERT) for Patients With Unresectable Pancreatic CancerAnnals of Surgery, 2005
- Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- COMBINED 5-FLUOROURACIL AND SUPERVOLTAGE RADIATION THERAPY OF LOCALLY UNRESECTABLE GASTROINTESTINAL CANCERThe Lancet, 1969